Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced that it has signed an agreement to acquire Redberry SAS (Redberry), an innovative company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology.

Redberry is a leader in SPC, providing rapid and highly precise microbial detection solutions for the pharmaceutical industry. Its state-of-the-art technology accelerates microbiology testing, delivering faster and more reliable results to ensure quality control and regulatory compliance. The innovative Red One™ System is designed for both rapid sterility and bioburden testing, to meet growing industry requirements for speed, sensitivity and ease of use.

In April 2025, Redberry announced the successful validation of its Red One™ rapid sterility testing method that delivers results in just four days. This breakthrough solution offers a robust, GMP-compliant alternative to traditional sterility testing, which typically requires a minimum incubation time of 14 days. This improved speed will help to meet the pharmaceutical industry's growing demand for faster product release without compromising safety or regulatory standards.